Using Diagnostic Tools to Stage Breast Cancer

University of Pennsylvania

Status: Active, not recruiting

Conditions: Breast Cancer

Treatments: Device: MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)

Study type: Interventional

Funder types: Other

Identifiers

NCT00367666

Protocol 414500

NIH funded

Details and patient eligibility

About

This project is aimed at investigating the relative diagnostic and synergy of four state of the art breast imaging techniques (magnetic resonance imaging (MRI), full-field digital mammography (DMAM), ultrasound, and positron emission tomography (PET)) with respect to determining the extent of breast cancer.

Enrollment: 400 estimated patients

Sex: Female

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women recently diagnosed with Breast Cancer
• Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania

Exclusion criteria

• Contraindications to MRI
• previously diagnosed with breast cancer (in the smae breast) within the past 5 years
• Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.
• Pregnant women

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

400 participants in 1 patient group

Patients Diagnosed with Breast Cancer

Experimental group

Treatment:

Device: MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)